AMARIN Company Profile

What is the competitive landscape for AMARIN

AMARIN has two approved drugs.

There are sixty-three US patents protecting AMARIN drugs.

There are three hundred and fifty-eight patent family members on AMARIN drugs in forty-six countries and twenty-two supplementary protection certificates in fourteen countries.

Summary for AMARIN

International Patents:	358
US Patents:	63
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for AMARIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-002	Feb 16, 2017	AB	RX	Yes	No	9,693,984
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-002	Feb 16, 2017	AB	RX	Yes	No	10,786,478
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-001	Jul 26, 2012	AB	RX	Yes	Yes	10,383,840
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-002	Feb 16, 2017	AB	RX	Yes	No	8,710,041
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-001	Jul 26, 2012	AB	RX	Yes	Yes	8,546,372
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-002	Feb 16, 2017	AB	RX	Yes	No	8,563,608

Expired US Patents for AMARIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-001	Jul 26, 2012	8,188,146
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE;ORAL	202057-002	Feb 16, 2017	8,188,146

Paragraph IV (Patent) Challenges for AMARIN drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	1 g		2016-07-26
	Capsules	1 g		2013-01-15
	Capsules	500 mg		2017-08-29

International Patents for AMARIN Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	3363433
Eurasian Patent Organization	039108
New Zealand	720946
South Korea	101465717
Brazil	112021005580
Australia	2020294210

Supplementary Protection Certificates for AMARIN Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2443246	LUC00226	Luxembourg		PRODUCT NAME: ICOSAPENT ETHYL; AUTHORISATION NUMBER AND DATE: EU/1/20/1524 20210329
2022495	132021000000154	Italy		PRODUCT NAME: ICOSAPENT ETILE(VAZKEPA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1524, 20210329
2443246	PA2021522,C2443246	Lithuania		PRODUCT NAME: IKOZAPENTO ETILAS; REGISTRATION NO/DATE: EU/1/20/1524 20210326
0113964	97C0037	Belgium		PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
2443246	CR 2021 00036	Denmark		PRODUCT NAME: ICOSAPENT ETHYL; REG. NO/DATE: EU/1/20/1524 20210329
2022495	C202130051	Spain		PRODUCT NAME: ICOSAPENTO DE ETILO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1524; DATE OF AUTHORISATION: 20210326; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1524; DATE OF FIRST AUTHORISATION IN EEA: 20210326

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Amarin Pharms